Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ:BEAT)

1.290 +0.060 (+4.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 105,245
Open 1.230
Bid (Size) 1.170 (4)
Ask (Size) 1.360 (8)
Prev. Close 1.230
Today's Range 1.170 - 1.290
52wk Range 1.170 - 3.480
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Present at iAccess Alpha Virtual Summer Conference
Via Investor Brand Network
Topics Intellectual Property
Updated Lineup Announced for iAccess Alpha's Virtual Summer Investment Conference, June 24–25, 2025
Via ACCESS Newswire

Performance

YTD
-45.1%
-45.1%
1 Month
-28.7%
-28.7%
3 Month
-34.2%
-34.2%
6 Month
-45.1%
-45.1%
1 Year
-56.3%
-56.3%

More News

Read More
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection
Via Investor Brand Network
Topics Intellectual Property
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025
Via ACCESS Newswire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia Join Forces to Advance Remote Cardiac Monitoring
Via Investor Brand Network
Topics Intellectual Property
HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG
Via Investor Brand Network
Topics Intellectual Property
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Reported Q1 2025 Results, Advanced Toward Commercialization Following VALID-ECG Study Success
Via Investor Brand Network
Topics Intellectual Property
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Reports First Quarter 2025 Results
From HeartBeam, Inc.
Via Business Wire
Two New U.S. Patents Bring Total to 20 Issued Worldwide, Cementing Company Leadership in Cardiac Monitoring Innovation for 12-Lead ECG Synthesis Technology: HeartBeam, Inc. (Nasdaq: BEAT)
Via Get News
Topics Intellectual Property
Earnings Scheduled For May 13, 2025
Via Benzinga
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Adds Two U.S. Patents to Bolster Cardiac Monitoring IP Portfolio
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints CEO Robert Eno to Board of Directors
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
From HeartBeam, Inc.
Via Business Wire
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Report Q1 2025 Results and Provide Business Update on May 13
Via Investor Brand Network
Topics Intellectual Property
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care: HeartBeam, Inc. (Nasdaq: BEAT)
Via Get News
Topics Intellectual Property
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Positive VALID-ECG Study Results Supporting 12-Lead ECG Technology
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
From HeartBeam, Inc.
Via Business Wire

Frequently Asked Questions

Is Heartbeam, Inc. - Common Stock publicly traded?
Yes, Heartbeam, Inc. - Common Stock is publicly traded.
What exchange does Heartbeam, Inc. - Common Stock trade on?
Heartbeam, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Heartbeam, Inc. - Common Stock?
The ticker symbol for Heartbeam, Inc. - Common Stock is BEAT on the Nasdaq Stock Market
What is the current price of Heartbeam, Inc. - Common Stock?
The current price of Heartbeam, Inc. - Common Stock is 1.290
When was Heartbeam, Inc. - Common Stock last traded?
The last trade of Heartbeam, Inc. - Common Stock was at 07/02/25 04:00 PM ET
What is the market capitalization of Heartbeam, Inc. - Common Stock?
The market capitalization of Heartbeam, Inc. - Common Stock is 44.20M
How many shares of Heartbeam, Inc. - Common Stock are outstanding?
Heartbeam, Inc. - Common Stock has 44M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.